3 ·Filed Apr 1, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
This is a standard regulatory filing with no immediate trading implications. Traders should monitor future Form 4 filings for any actual insider buying or selling activity.
Final — all horizons settled through T+60d
DSGN ▲ +28.85% at T+60d
NEUTRAL call +28.85% · α vs SPY +14.69% · entry $11.23 → $14.47
T+1d
+11.58%
call +11.58% · α +11.10%
$12.53
settled 7mo ago
T+5d
+8.28%
call +8.28% · α +4.66%
$12.16
settled 7mo ago
T+20d
+21.10%
call +21.10% · α +11.23%
$13.60
settled 6mo ago
T+60d
+28.85%
call +28.85% · α +14.69%
$14.47
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
David Shapiro, a director or 10% owner of Design Therapeutics, Inc., filed a Form 3 to report his initial beneficial ownership and appointed Sean Jeffries and Mustapha Parekh as attorneys-in-fact to file SEC Forms 3, 4, and 5 on his behalf. This is a routine compliance filing related to insider reporting obligations.
Key Facts
- David Shapiro filed Form 3 as a director or 10% shareholder of DSGN.
- He granted power of attorney to Sean Jeffries and Mustapha Parekh to file SEC Forms 3, 4, and 5 on his behalf.
- The filing was made on April 1, 2026, with a reporting period end date of March 31, 2026.
- No transactions or changes in ownership were disclosed in this filing.
Financial Impact
No financial impact disclosed
Risk Factors
- None identified from this filing
- Lack of disclosed ownership details limits insight into potential future insider transactions
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001559570-26-000004 |
| Document: 0001559570-26-000004-index-headers.html | 0001559570-26-000004 |
| Document: 0001559570-26-000004-index.html | 0001559570-26-000004 |
| Document: 0001559570-26-000004.txt | 0001559570-26-000004 |
8 reports for DSGN
80% Hit rate @ T+20 Went positive at some point 4 of 5 best @ T+60▲ +37.01%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 3, 2026 12w ago | 8-K | $12.76 $15.09 | ▲ +18.26% | ▲ +17.02% | $10.34 (−18.97%) |
Aug 3, 2026 12w ago | Press Release | $12.76 $15.09 | ▲ +18.26% | ▲ +17.02% | $10.34 (−18.97%) |
May 18, 2026 23w ago | 8-K | $10.70 $10.72 | ▲ +0.19% | ▼ −1.39% | $10.34 (−3.36%) |
May 18, 2026 23w ago | Press Release | $10.70 $10.72 | ▲ +0.19% | ▼ −1.39% | $10.34 (−3.36%) |
May 17, 2026 23w ago | Press Release | $10.70 $10.72 | ▲ +0.19% | ▼ −1.39% | $10.34 (−3.36%) |
Apr 28, 2026 25w ago | Press Release | $15.79 $11.10 | ▼ −29.70% | ▼ −35.16% | $10.34 (−34.52%) |
Apr 23, 2026 26w ago | DEFA14A | $12.53 $11.01 | ▼ −12.13% | ▼ −16.16% | $10.34 (−17.48%) |
Apr 1, 2026 29w ago | 3 | $11.23 $13.60 | ▲ +21.10% | ▲ +11.23% | $10.34 (−7.93%) |
Showing 8 of 8
US Market Status
Market Closed — Opens Tue (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers